%0 Journal Article
%T Radical stereotactic radiosurgery with real-time tumor motion tracking in the treatment of small peripheral lung tumors
%A Brian T Collins
%A Kelly Erickson
%A Cristina A Reichner
%A Sean P Collins
%A Gregory J Gagnon
%A Sonja Dieterich
%A Don A McRae
%A Ying Zhang
%A Shadi Yousefi
%A Elliot Levy
%A Thomas Chang
%A Carlos Jamis-Dow
%A Filip Banovac
%A Eric D Anderson
%J Radiation Oncology
%D 2007
%I BioMed Central
%R 10.1186/1748-717x-2-39
%X Eligible patients were treated over a 24-month period and followed for a minimum of 6 months. Fiducials (3¨C5) were placed in or near tumors under CT-guidance. Non-isocentric treatment plans with 5-mm margins were generated. Patients received 45¨C60 Gy in 3 equal fractions delivered in less than 2 weeks. CT imaging and routine pulmonary function tests were completed at 3, 6, 12, 18, 24 and 30 months.Twenty-four consecutive patients were treated, 15 with stage I lung cancer and 9 with single lung metastases. Pneumothorax was a complication of fiducial placement in 7 patients, requiring tube thoracostomy in 4. All patients completed radiation treatment with minimal discomfort, few acute side effects and no procedure-related mortalities. Following treatment transient chest wall discomfort, typically lasting several weeks, developed in 7 of 11 patients with lesions within 5 mm of the pleura. Grade III pneumonitis was seen in 2 patients, one with prior conventional thoracic irradiation and the other treated with concurrent Gefitinib. A small statistically significant decline in the mean % predicted DLCO was observed at 6 and 12 months. All tumors responded to treatment at 3 months and local failure was seen in only 2 single metastases. There have been no regional lymph node recurrences. At a median follow-up of 12 months, the crude survival rate is 83%, with 3 deaths due to co-morbidities and 1 secondary to metastatic disease.Radical stereotactic radiosurgery with real-time tumor motion tracking is a promising well-tolerated treatment option for small peripheral lung tumors.Treatment options for medically inoperable patients with lung cancer are limited. Poor outcomes with protracted conventionally fractionated radiotherapy approaches prompted researchers in the last decade to explore ways of delivering high doses of radiation in shorter periods of time [1]. Utilizing a body frame and abdominal compression to limit lung motion, small mobile lesions have been treated with r
%U http://www.ro-journal.com/content/2/1/39